|
受注:045-509-1970 |
技術サポート:tech@selleck.co.jp 平日9:00〜18:00 1営業日以内にご連絡を差し上げます |
製品コード:A2051 Batch: A205108
Human IgG1 isotype control is suitable for use as a non-targeting isotype control in various in vitro and in vivo studies.
| Formulation | 100 mM Pro, 20 mM Arg, pH 5.0 |
|---|---|
| Clone | R1 |
| Isotype | human IGg1, κ |
| Application | Human IgG1 isotype control |
| Source | CHO |
| Storage (From the date of receipt) |
Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles |
| Shipping | Shipped under low temperature conditions |
| Purity | 99% |
| Protein concentration | 7.874mg/ml |
| Endotoxin Level | <1EU/mg |
| F3 Expression Drives Sensitivity to the Antibody-Drug Conjugate Tisotumab Vedotin in Glioblastoma [ Cancers (Basel), 2025, 17(5)834] | PubMed: 40075681 |
| Targeting RPE Senescence Via Suppressing IL-6/IL-6R Signaling for Treating Retinal Degenerative Diseases [ Invest Ophthalmol Vis Sci, 2025, 66(12):44] | PubMed: 40970669 |
| LILRB4 on multiple myeloma cells promotes bone lesion by p-SHP2/NF-κB/RELT signal pathway [ J Exp Clin Cancer Res, 2024, 43(1):183] | PubMed: 38951916 |
| Inhibition of Cbl-b restores effector functions of human intratumoral NK cells [ J Immunother Cancer, 2024, 12(11)e009860] | PubMed: 39551607 |
| Targeting CD47 and Angiogenesis Demonstrates Effective Anti-Tumor Effect in Bladder Cancer [ Biomedicines, 2024, 12(9)2152] | PubMed: 39335665 |
人間や獣医の診断であるか治療的な使用のためにでない。